Pfizer - International Biopharmaceutical Industry

news

Pfizer gene therapy research delayed by trial changes, safety questions

In both hemophilia and Duchenne, unexpected findings have led Pfizer to redraw its development plans. The company recently paused patient screening and dosing in a P...

8 November 2021 news gene therapy | hemophilia

Continue Reading →

news

CDC panel unanimously backs use of Pfizer’s COVID-19 vaccine in young children

The CDC meeting Tuesday emphasized COVID-19's cost on young children, who, while less at risk than older adults, are still susceptible to disease, hospitalization and...

8 November 2021 news 5-11 year olds | CDC

Continue Reading →

news

FDA advisers support Pfizer’s coronavirus vaccine for young children

A group of advisers to the Food and Drug Administration on Tuesday endorsed use of Pfizer's coronavirus vaccine in younger children, judging the benefits of the shot ...

29 October 2021 news cases | coronavirus

Continue Reading →

news

J&J foresees end to not-for-profit sales of coronavirus vaccine

J&J has recorded far fewer sales of its coronavirus vaccine than competitors Pfizer and Moderna, partly due to its not-for-profit pricing but also to a series of ...

22 October 2021 news coronavirus vaccine | J&J

Continue Reading →

news

CDC panel levels playing field for new Merck, Pfizer pneumonia vaccines

This is the first time government advisers have recommended routine use of a pneumococcal vaccine for certain risk groups within the 19-64 age bracket, a move that co...

22 October 2021 news 19-64 age | Cantor Fitzgerald

Continue Reading →

news

Gene therapy developer gets chance at a comeback with Pfizer deal

Voyager's first generation of gene therapies for ALS, Parkinson's and Huntington's disease, all now discontinued, relied on a direct infusion into brain tissue, an in...

8 October 2021 news ALS | drugmaker

Continue Reading →

news

Sarepta embarks on late-stage clinical trial of Duchenne gene therapy

Although Pfizer beat Sarepta to start a Phase 3 trial of its gene therapy, the smaller biotech is claiming a milestone in initiating the study in the U.S. as well as ...

8 October 2021 news Biotech | Duchenne

Continue Reading →

news

J&J asks FDA to clear booster dose of its coronavirus vaccine

For the past several months, one of the many questions hanging over the booster debate has ben what do with people who got J&J's shot. The company's application, ...

8 October 2021 news Centers of Disease Control and Prevention | coronavirus vaccine

Continue Reading →

news

Pfizer, marking fast research pace, starts key trial of RSV vaccine

A vaccine against RSV has proven elusive despite decades of attempts. Pfizer is moving at a surprisingly quick pace to catch up to rivals led by GlaxoSmithKline, who ...

3 September 2021 news GlaxoSmithKline | GSK

Continue Reading →

news

FDA grants full approval to Pfizer, BioNTech’s coronavirus vaccine

The Food and Drug Administration on Monday granted full approval to Pfizer and BioNTech's coronavirus vaccine, a long-awaited decision that government officials hope ...

27 August 2021 news BioNTech | coronavirus vaccine

Continue Reading →